Showing results (301-310 of 476) with videos related to
Sort By:
Pageof 48
The Journal of Urology|May 25, 2021
A Contemporary Analysis of Urethral Recurrence following Radical CystectomyAbhinav Khanna, Andrew Zganjar, Timothy Lyon, et al.Urology|July 30, 2013
Percutaneous renal cryoablation in obese and morbidly obese patientsGrant D Schmit, R Houston Thompson, Stephen A Boorjian, et al.Urologic Oncology|November 26, 2019
The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomyVignesh T Packiam, Mark D Tyson Ii, Matvey Tsivian, et al.The Journal of Urology|April 12, 2017
Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing NephrectomyDavid Y Yang, R Houston Thompson, Harras B Zaid, et al.Cancer|June 24, 2005
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressivenessShomik Sengupta, Christine M Lohse, Bradley C Leibovich, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinomaXavier Frigola, Brant A Inman, Christine M Lohse, et al.World Journal of Urology|November 5, 2018
A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk diseaseTimothy D Lyon, Igor Frank, Vidit Sharma, et al.The Journal of Urology|November 6, 2012
Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomesRyan M Hegg, Grant D Schmit, Stephen A Boorjian, et al.Journal of Vascular and Interventional Radiology : JVIR|March 7, 2018
A Comparison of Bleeding Complications in Patients Undergoing Percutaneous Renal Cryoablation Using Cryoprobes with and without Heat-Based Track AblationCollin H Schmit, Matthew R Callstrom, Stephen A Boorjian, et al.The Journal of Urology|September 6, 2022
Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov ModelVidit Sharma, Kevin M Wymer, Daniel D Joyce, et al.Pageof 48